This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

ICAD Expands Access To The Xoft System For Treating Non-Melanoma Skin Cancer To Dermatology Centers Via A Strategic Alliance With DermEbx

iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer, today announced a strategic alliance with DermEbx™ to offer the Xoft ® Axxent ® Electronic Brachytherapy System ® to treat non-melanoma skin cancer (NMSC) throughout the DermEbx network of dermatology centers. DermEbx currently services 14 locations in Arizona, California and Nevada with Xoft System units placed in all locations.

“We are pleased to provide patients diagnosed with non-melanoma skin cancer this innovative and effective treatment option that is administered in their dermatologist’s office under the supervision of a radiation oncologist,” said Ken Ferry, iCAD’s CEO. “Electronic brachytherapy is a proven, non-invasive alternative to surgery, and this strategic alliance will allow us to expand the number of systems we have in place to treat more patients at centers managed by DermEbx. This agreement provides patients with a proven, convenient treatment alternative in a familiar care environment.”

“We are excited to bring the Xoft System to our managed centers as part of this strategic alliance,” said Kamal Gogineni, President of DermEbx. “The collaboration between DermEbx, dermatologists and its affiliated radiation oncologists will help create a comprehensive solution for this advanced technology in treating skin cancer patients.”

“DermEbx integrates the mobile Xoft System into its dermatology centers by allowing treatment to occur in the facility where the diagnosis is made, potentially eliminating the need to visit multiple service providers at different locations,” said David Berman, M.D., Medical Director, Berman Gladstone Skin Institute. “The mobility of the Xoft System enables a radiation oncologist to treat more patients at multiple dermatology centers.”

About Non-Melanoma Skin Cancer

NMSC, identified as either basal cell carcinoma or squamous cell carcinoma, is not only the most common type of skin cancer, it is the most common type of cancer in humans. These cancers commonly appear on sun-exposed areas of the body such as the face, ears, neck, lips and backs of the hands. NMSC affects approximately 2.2 million Americans each year.

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,098.45 +18.88 0.11%
S&P 500 2,003.37 +6.63 0.33%
NASDAQ 4,580.2710 +22.5760 0.50%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs